Andrew Marshall has been Editor of Nature Biotechnology since 2000. Since that time, the journal’s impact factor has increased from 11.0 to 41.5. It is currently the top research journal in biotechnology and among the top 20 primary research journals in the world. As well as frequently speaking on biotechnology issues at international meetings, he also regularly heads and organizes conferences and symposia for the journal. He has over 20 years of experience in scientific publishing, and was previously Editor of Current Opinion in Biotechnology from 1992 to 1996. He has written over 200 articles and editorials on science and technology for the popular media, including The Economist and Popular Science, and for trade publications. In 2003, he launched Nature Biotechnology’s free-access web portal Bioentrepreneur providing practical information and advice on the challenges of starting a biotechnology enterprise. Since 2007, he has been hosting the networking events in Boston, San Francisco, San Diego, Houston, London and now New York, which showcase rising stars in academia to angels, VCs and industry R&D leaders. He obtained a BSc with Honors and his PhD and postdoctoral experience in molecular biology and microbiology at King’s College London. He is the recipient of the Helen White Prize.